| We are very excited to announce that Lasse Nørregaard has joined DANISH BIO’s board as an observer!
Lasse has in just a few years created an impressive track record in the early-stage life science space, and has across six different start-ups successfully been part of raising over €35 million in several fundraising rounds. Beyond his entrepreneurial success, Lasse has been heavily involved in the biotech ecosystem on many fronts, being chairman of REBBLS and staying actively involved with advising university spin-outs from DTU and KU, and teaching finance at CBS. Currently, Lasse is dividing his time between XY Therapeutics, Loma Therapeutics and Probmet, and has previously been in Kesmalea Therapeutics, BOOST Pharma and Epoqe Pharma. We wish Lasse a warm welcome and look forward to working with him to create even better frameworks for biotech in Denmark. |
 |